Comments for AGIX - Stockpickr! Your Source for Stock Ideas

Comments for AGIX

Added By	Comments	Type	Date Added
Thom Clark	Another dumb move	Love	May 12, 2008
Taxman33	looser	Hate	January 30, 2008
mroyal	I intend to ride this stock up to around $6 a share once the phase III data is presented to the FDA and the European medical community. Look for the diabetes drug to get favorable treatment by the FDA for expedited processing.	Love	September 19, 2007
bobbiemac	a longshot...interesting new direction on diabetes treatment as a new direction for its current no 1 investigational drig... obtaining a new sponser will ramp it up.. fairly big shorts will cause massive spike	Love	July 19, 2007
samuelgroom	severely beaten down in the cardiovascular arena. now trying to come back as a diabetes preventing medicine. with recent black box warning for the tzd's, may have a chance.	Love	July 08, 2007
gregwebb	new application for drug reccomended by MD flatline have not purchased yet will wait for market to show interest	Love	June 22, 2007
BigAl7734	Niotech speculation	Hate	June 21, 2007
Thyro	Moon in Jupiter	Love	May 23, 2007
Lew	Low price	Love	May 10, 2007
don4847g	Technical	Love	May 06, 2007
student007	Drugs in phrase 2 testing, loss narrowed	Love	May 04, 2007
HotHungarian	Confirmed bottom after selloff	Love	April 27, 2007
betty pratt	profits just taken	Love	April 18, 2007
Prestonjr00	If they ever come up with a better "mousetrap" for controlling pain related to arthritus this could be a $30 stock	Love	April 16, 2007
intimidatortj	Stock got hammered on bad news recently. Can't go anywhere but up over the next 1 to 2 years.	Love	April 06, 2007
Bill Harper	possibles	Love	February 26, 2007
william macdonald	potential block buster drug	Love	February 03, 2007
Cross	New drug AGI-1067 should pass efficacy trial for athlerosclrosis. If it passes, stock could go to $40 or $50, if it fails it goes to $2	Love	January 31, 2007
Michael Curran	Simply so I could buy the cover call option 12.50 for April at $5+ a share.	Love	January 31, 2007
Paul Carrz	short size is massive	Love	January 30, 2007
paul simenauer	AtheroGenics, Inc. (AtheroGenics) is a research-based pharmaceutical company that focuses on the discovery, development and commercialization of novel drugs for the treatment of chronic inflammatory diseases, including coronary heart disease (CHD), organ transplant rejection, rheumatoid arthritis and asthma. The Company has developed the v-protectant technology platform to discover drugs to treat these types of diseases.	Love	January 26, 2007
tab gilles	Has blockbuster drug AGI-1067 in phase 3, to announce soon if approved. Could be a huge deal $4billion drug. Stock could triple in 2 years.	Love	January 25, 2007
jason mah	The thing i dont like about atherogenics, is that it seems they are withholding information. We know they submitted results on their phase III trial, for a presentation in march. So the results are out there. But they are waiting till they get the full dataset before they release the results. I just dont trust it. If they had positive results, they would have release the data, as soon as possible. The only reason I can think of by withholding the data, is that it is negative, and they are data mining for any good details.	Hate	January 11, 2007
Steve Beban	Speculative bottle rocket once FDA approves	Love	January 10, 2007